Celldex Therapeutics, Inc. (CLDX)

R1 RCM Market Cap

Celldex Therapeutics has a market cap or net worth of $1.47 billion as of August 1, 2025. Its market cap has decreased by -42.36% in one year.

• Market Cap: 1.47B
• Enterprise Value: 803.43M
• 1-Year Change: -42.36%
• Ranking: #2140
• Category: Small-Cap
• Stock Price: $22.19

Market Cap Chart

Since July 23, 2003, Celldex Therapeutics's market cap has increased from $148.10M to $1.47B, an increase of 894.79%. That is a compound annual growth rate of 10.99%.

Market Cap History

Date	Market Cap	% Change
Aug 1, 2025	1.47B	-12.12%
Dec 31, 2024	1.68B	-10.56%
Dec 29, 2023	1.87B	-10.70%
Dec 30, 2022	2.10B	16.42%
Dec 31, 2021	1.80B	160.11%
Dec 31, 2020	693.20M	1,825.56%
Dec 31, 2019	36.00M	5.57%
Dec 31, 2018	34.10M	-91.17%
Dec 29, 2017	386.20M	7.76%
Dec 30, 2016	358.40M	-76.83%
Dec 31, 2015	1.55B	-5.39%
Dec 31, 2014	1.64B	-16.73%
Dec 31, 2013	1.96B	372.13%
Dec 31, 2012	415.90M	262.28%
Dec 30, 2011	114.80M	-13.10%
Dec 31, 2010	132.10M	-10.50%
Dec 31, 2009	147.60M	17.99%
Dec 31, 2008	125.10M	237.20%
Dec 31, 2007	37.10M	-62.68%
Dec 29, 2006	99.40M	-28.69%
Dec 30, 2005	139.40M	-6.44%
Dec 31, 2004	149.00M	-15.96%
Dec 31, 2003	177.30M	19.72%
Jul 23, 2003	148.10M	-

View and export this data all the way back to 2003. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	680.31B
Johnson & Johnson	400.22B
AbbVie	344.89B
AstraZeneca	232.21B
Novartis AG	224.47B
Abbott Laboratories	221.60B
UnitedHealth Group	219.69B
Novo Nordisk	213.92B